J. Farmer

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

The effect of digoxin on mortality and morbidity in patients with heart failure.

E. J. Brown, Hack, D. M. Barr, 1997, The New England journal of medicine.

Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE)

N. Waugh, S. Heller, M. Bradburn, 2017, British Medical Journal.